Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06372626
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-04-15
Brief Title:
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma
Sponsor:
Suzhou Zelgen Biopharmaceuticals CoLtd
Organization:
Suzhou Zelgen Biopharmaceuticals CoLtd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroendocrine Carcinoma |
Keywords: